Get my own profile
Public access
View all44 articles
7 articles
available
not available
Based on funding mandates
Co-authors
Ola EngkvistAstraZeneca R&D Gothenburg Orcid:0000-0003-4970-6461Verified email at astrazeneca.com
Lars CarlssonRTHS and CRML, University of London, Jönköping UniversityVerified email at rhul.ac.uk
Thierry KogejAssociate Principal Scientist, AstraZenecaVerified email at astrazeneca.com
Sorel MuresanGlobal R&D Manager Cleaning Goods, Nouryon, Stenungsund SwedenVerified email at nouryon.com
Jiangming SunLund UniversityVerified email at med.lu.se
Igor V. TetkoBIGCHEM GmbH & Helmholtz MunichVerified email at helmholtz-munich.de
Yidong YangMolecular Oncology, BC Cancer Research CentreVerified email at bccrc.ca
John G. Cumming, PhDExperienced medicinal chemist, AstraZeneca PharmaceuticalsVerified email at astrazeneca.com
Niklas BlombergDirector, ELIXIRVerified email at ebi.ac.uk
Andrew M DavisAstraZeneca, Fisons, Astra, University of KentVerified email at astrazeneca.com
Markus FridenRIA iMed, AstraZenecaVerified email at astrazeneca.com
Antonio LlinàsRIA iMed AstraZenecaVerified email at astrazeneca.com
JG KennaPharmaceutical DirectorVerified email at safermedicines.org
Antonsson MadeleineAstraZenecaVerified email at astrazeneca.com
Mats SvenssonVerified email at schrodinger.com
Daniel WarnerDrafKings Inc.
Follow![Hongming Chen](/citations/images/avatar_scholar_128.png)
![Hongming Chen](/citations/images/avatar_scholar_128.png)
Hongming Chen
Astrazeneca, Bioland Laboratory, Guangzhou Laboratory
Verified email at grmh-gdl.cn